| 13.01.2021 16:35 | | Price Monitoring Extension | RNS |
| 13.01.2021 07:00 | | Finalization of MCIT rule for coverage pathway | RNS |
| 05.01.2021 16:41 | | Second Price Monitoring Extn | RNS |
| 05.01.2021 16:36 | | Price Monitoring Extension | RNS |
| 05.01.2021 07:00 | | Partnership Between RenalytixAI and DaVita | RNS |
| 07.12.2020 15:45 | | Result of AGM | RNS |
| 02.12.2020 13:08 | | Partnership with National Kidney Foundation | RNS |
| 26.11.2020 07:01 | | Holding(s) in Company | RNS |
| 26.11.2020 07:00 | | Sale of shares in Renalytix AI plc | RNS |
| 25.11.2020 16:41 | | Second Price Monitoring Extn | RNS |
| 25.11.2020 16:35 | | Price Monitoring Extension | RNS |
| 25.11.2020 07:00 | | Financial Results for First Quarter of FY 2021 | RNS |
| 06.11.2020 07:00 | | Change of Adviser | RNS |
| 02.11.2020 15:30 | | Posting of Annual Report & Accounts &Notice of AGM | RNS |
| 28.10.2020 14:15 | | Re-issued: EKF marketing & distribution agreement | RNS |
| 27.10.2020 07:00 | | Full Year Report | RNS |
| 20.10.2020 11:00 | | Schedule One - Verici Dx PLC | RNS |
| 16.10.2020 06:00 | | Notice of Results | RNS |
| 13.10.2020 14:32 | | Verici Dx - Intention to admit to trading on AIM | RNS |
| 22.09.2020 06:00 | | California Commercial Lab Certification Recieved | RNS |
| 18.09.2020 06:00 | | KidneyIntelX clinical testing launch | RNS |
| 02.09.2020 06:00 | | Grant of Purchase Rights and Verici update | RNS |
| 26.08.2020 06:00 | | Submission seeking FDA Clearance of KidneyIntelX | RNS |
| 21.08.2020 07:00 | | RenalytixAI to Collaborate with AstraZeneca | RNS |
| 03.08.2020 06:00 | | KidneyIntelX in Multi-Center Study | RNS |
| 31.07.2020 15:31 | | Total Voting Rights | RNS |
| 27.07.2020 06:00 | | Over allotment option exercise | RNS |
| 21.07.2020 16:30 | | Closing of Global Offering and resulting TVR | RNS |
| 17.07.2020 06:00 | | Pricing of Global Offering | RNS |
| 13.07.2020 11:01 | | Launch of Global Offering and application to list | RNS |
| 13.07.2020 10:45 | | Result of General Meeting | RNS |
| 08.07.2020 06:01 | | Approval of distribution of shares in Verici Dx | RNS |
| 08.07.2020 06:00 | | Partnership with America’s Choice Provider Network | RNS |
| 07.07.2020 06:00 | | Holding(s) in Company | RNS |
| 30.06.2020 06:00 | | University of Michigan Partnership & Data Sharing | RNS |
| 25.06.2020 06:01 | | Proposed Board changes; Circular & Notice of GM | RNS |
| 25.06.2020 06:00 | | Public filing re. Nasdaq dual-listing and offering | RNS |
| 12.06.2020 06:00 | | KidneyIntelX™ receives New York State approval | RNS |
| 10.06.2020 07:00 | | Confirmation of reduction of capital | RNS |
| 10.06.2020 06:00 | | Positive results of clinical validation study | RNS |
| 20.05.2020 10:06 | | Second Price Monitoring Extn | RNS |
| 20.05.2020 10:00 | | Price Monitoring Extension | RNS |
| 20.05.2020 06:00 | | JV for COVID-19 antibody test scaled production | RNS |
| 18.05.2020 06:00 | | Proposed dual-listing on Nasdaq | RNS |
| 15.05.2020 12:02 | | Result of General Meeting | RNS |
| 05.05.2020 09:55 | | Removal of US Securities Law Restrictions | RNS |
| 28.04.2020 06:00 | | Update re. potential demerger of FractalDx | RNS |
| 20.04.2020 06:00 | | KidneyIntelX used in Mount Sinai COVID-19 study | RNS |
| 15.04.2020 06:00 | | Provider network agreement for KidneyIntelX™ | RNS |
| 01.04.2020 06:00 | | Medicare provider number | RNS |
| 27.03.2020 10:32 | | Holding(s) in Company | RNS |
| 03.03.2020 07:00 | | Half-year Report | RNS |
| 26.02.2020 07:00 | | Notice of Results | RNS |
| 08.01.2020 07:00 | | New commercial testing facility opens in Utah | RNS |
| 03.12.2019 07:00 | | Medicare sets US national price for KidneyIntelX | RNS |
| 21.11.2019 07:00 | | Grant of Options | RNS |
| 17.10.2019 06:00 | | Partnership with CDPHP on KidneyIntelX | RNS |
| 14.10.2019 06:00 | | Board appointment | RNS |
| 01.10.2019 06:00 | | US CPT® reimbursement code effective | RNS |
| 30.09.2019 15:37 | | Result of AGM | RNS |
| 30.09.2019 07:00 | | Update on non-executive director appointment | RNS |
| 30.09.2019 06:00 | | Preliminary Medicare Pricing Determination | RNS |
| 06.09.2019 15:00 | | Posting of Annual Report & Accounts &Notice of AGM | RNS |
| 03.09.2019 06:00 | | Final Results | RNS |
| 20.08.2019 06:00 | | Notice of Results | RNS |
| 06.08.2019 06:00 | | Expansion of Chronic Kidney Disease Advisory Board | RNS |
| 31.07.2019 15:30 | | Total Voting Rights | RNS |
| 23.07.2019 17:23 | | Result of Placing & Total Voting Rights | RNS |
| 23.07.2019 06:01 | | Proposed Placing to raise £12.0m (c.US$15.0m) | RNS |
| 09.07.2019 06:00 | | Positive Interim Results for Validation Study | RNS |
| 01.07.2019 06:00 | | US CPT® Code Granted for KidneyIntelX(TM) | RNS |
| 02.05.2019 13:05 | | Second Price Monitoring Extn | RNS |
| 02.05.2019 13:00 | | Price Monitoring Extension | RNS |
| 02.05.2019 06:00 | | FDA grants Breakthrough Device designation | RNS |
| 26.04.2019 17:20 | | Acquisition of further interest in Renalytix AI | RNS |
| 26.04.2019 16:42 | | Director/PDMR Shareholding | RNS |
| 02.04.2019 11:55 | | Holding(s) in Company | RNS |
| 01.04.2019 06:00 | | Publication of confirmation study results | RNS |
| 25.03.2019 07:00 | | Half-year Report | RNS |
| 14.02.2019 07:00 | | Appointment of Nomad and Joint Broker | RNS |
| 13.02.2019 07:00 | | Joint venture partnership agreement with AKESOgen | RNS |
| 23.01.2019 07:00 | | Initiates Clinical Validation Study | RNS |
| 21.01.2019 07:00 | | Clarification re. lock-up restrictions | RNS |
| 02.01.2019 07:00 | | Exercise of Option for Exclusive License | RNS |
| 20.12.2018 17:20 | | Director/PDMR Shareholding | RNS |
| 20.12.2018 07:01 | | Planned appointment of joint broker & of NOMAD | RNS |
| 19.12.2018 18:28 | | Director Dealing | RNS |
| 17.12.2018 13:30 | | Holding(s) in Company | RNS |
| 09.11.2018 10:30 | | Holding(s) in Company | RNS |
| 08.11.2018 16:50 | | Holding(s) in Company | RNS |
| 08.11.2018 07:00 | | Director/PDMR Shareholding | RNS |
| 06.11.2018 07:00 | | RENX Admission to AIM and First Day of Dealings | RNS |
